Oral GLP-1 Therapy for Obesity and Type 2 Diabetes
A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings…
A new oral GLP-1 medication can help adults with obesity and Type 2 diabetes lose more weight and improve their blood sugar levels compared to a placebo, according to findings…
Obesity is no longer a looming crisis – it’s a present and escalating public health emergency across Europe. More than half of EU adults are now overweight, and nearly one…
According to reports, the US could deny a visa to applicants with certain health issues, which include diabetes, heart disease, and …
The United States has introduced new guidance that could see foreign nationals denied visas or green cards on the basis of pre-existing chronic health conditions, including diabetes, obesity, and heart…
November 05, 2025 4 min read Add topic to email alerts Receive an email when new articles are posted on Please provide your email…
Innovent Biologics, Inc.’s investigative GLP-1/glucagon (GCG) dual receptor agonist mazdutide has met its primary endpoint of superiority to semaglutide in HbA1c and body weight reduction in patients with type 2…
Want to watch Dr. Mark Cucuzella’s full talk and hear from more experts about transforming healthcare? To unlock access to all …
MM device used to deliver low-dose PEMF. The device measures 50 cm (W) × 60 cm (L) × 110 cm (H), with a treatment chamber with an internal diameter of…
Diagnoses of diabetes have reached an all-time high despite a “statistically meaningful decrease” in the U.S. adult obesity rate, Gallup reported. The diabetes rate is now at 13.8 percent, the…
artificial intelligence (ai) It offers predictive analytics to transform dietary management for diabetes and obesity, personalized nutritional planning, real-time glucose monitoring, and improve patient outcomes.AI-driven tools analyse dietary habits, metabolic…